These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 30877215)

  • 21. [Eculizumab as rescue therapy for lupus nephritis-related thrombotic microangiopathy].
    Fani FM; Patera A; Delsante M; Rossi GM; Manenti L; Landini S; Regolisti G; Fiaccadori E
    G Ital Nefrol; 2020 Jun; 37(3):. PubMed ID: 32530153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiphospholipid Syndrome Nephropathy and Other Thrombotic Microangiopathies Among Patients With Systemic Lupus Erythematosus.
    Kotzen ES; Roy S; Jain K
    Adv Chronic Kidney Dis; 2019 Sep; 26(5):376-386. PubMed ID: 31733722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thrombotic microangiopathy mediates poor prognosis among lupus nephritis
    Zhang B; Xing G
    Front Immunol; 2022; 13():1081942. PubMed ID: 36582241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective role of anti-ribosomal P antibody in patients with lupus nephritis.
    Kang JH; Park DJ; Choi SE; Yim YR; Kim JE; Lee JW; Lee KE; Kim TJ; Park YW; Lee JS; Choi YD; Lee JK; Lee SS
    Int J Rheum Dis; 2019 May; 22(5):913-920. PubMed ID: 30809965
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk Factors and Clinical Outcomes of Renal Thrombotic Microangiopathy in Children with Lupus Nephritis in Terms of Pathological and Clinical Features.
    Zhang P; Yang X; Fu MZ; Gao CL; Fang X; Xia ZK
    Nephron; 2024; 148(9):609-617. PubMed ID: 38852577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome of biopsy-proven lupus nephritis with low glomerular filtration rate at presentation.
    Haridasan S; Rathi M; Sharma A; Nada R; Kumar S; Ramachandran R; Kohli HS
    Int J Rheum Dis; 2020 Aug; 23(9):1201-1209. PubMed ID: 32677761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term renal outcomes in multi-ethnic Southeast Asians with lupus nephritis: a retrospective cohort study.
    Lim CC; Tan HZ; Hao Y; Chin YM; Woo KT; Chan CM; Choo JCJ
    Intern Med J; 2018 Sep; 48(9):1117-1123. PubMed ID: 29740923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morphological Indexes: Can They Predict Lupus Nephritis Outcomes? A Retrospective Study.
    Navarro D; Ferreira AC; Viana H; Carvalho F; Nolasco F
    Acta Med Port; 2019 Oct; 32(10):635-640. PubMed ID: 31625875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spectrum of renal vascular lesions among patients with lupus nephritis: An experience from a tertiary care center.
    Paul M; Addya S; Sengupta M; Basu K; Roychowdhury A; Bandopadhyay M
    Indian J Pathol Microbiol; 2023; 66(4):751-757. PubMed ID: 38084527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors to predict the development of chronic kidney disease in patients with lupus nephritis.
    Park DJ; Kang JH; Lee JW; Lee KE; Kim TJ; Park YW; Lee JS; Choi YD; Lee SS
    Lupus; 2017 Oct; 26(11):1139-1148. PubMed ID: 28420060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical characteristics and prognosis of diffuse proliferative lupus nephritis with thrombotic microangiopathy.
    Hu WX; Liu ZZ; Chen HP; Zhang HT; Li LS; Liu ZH
    Lupus; 2010 Dec; 19(14):1591-8. PubMed ID: 20798137
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What is the value of repeat kidney biopsies in patients with lupus nephritis?
    Morales E; Trujillo H; Bada T; Alonso M; Gutiérrez E; Rodríguez E; Gutiérrez E; Galindo M; Praga M
    Lupus; 2021 Jan; 30(1):25-34. PubMed ID: 33081588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of end-stage renal disease and recurrence of lupus activity after initiation of dialysis in patients with lupus nephritis.
    Moon SJ; Park HS; Kwok SK; Ju JH; Kim HY; Park SH
    Clin Exp Rheumatol; 2013; 31(1):31-9. PubMed ID: 22935632
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expanding the therapeutic options for renal involvement in lupus: eculizumab, available evidence.
    Sciascia S; Radin M; Yazdany J; Tektonidou M; Cecchi I; Roccatello D; Dall'Era M
    Rheumatol Int; 2017 Aug; 37(8):1249-1255. PubMed ID: 28258475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal Remission Status and Longterm Renal Survival in Patients with Lupus Nephritis: A Retrospective Cohort Analysis.
    Davidson JE; Fu Q; Ji B; Rao S; Roth D; Magder LS; Petri M
    J Rheumatol; 2018 May; 45(5):671-677. PubMed ID: 29496892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Renal thrombotic microangiopathy and antiphospholipid syndrome nephropathy in a patient with lupus nephritis].
    Sakamaki Y; Konishi K; Hashiguchi A; Tomita S; Kubota E; Itoh H; Hayashi K
    Nihon Jinzo Gakkai Shi; 2016; 58(1):45-54. PubMed ID: 26950981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and Histopathologic Characteristics Associated with Renal Outcomes in Lupus Nephritis.
    Rijnink EC; Teng YKO; Wilhelmus S; Almekinders M; Wolterbeek R; Cransberg K; Bruijn JA; Bajema IM
    Clin J Am Soc Nephrol; 2017 May; 12(5):734-743. PubMed ID: 28473317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal vascular lesions in lupus nephritis.
    Descombes E; Droz D; Drouet L; Grünfeld JP; Lesavre P
    Medicine (Baltimore); 1997 Sep; 76(5):355-68. PubMed ID: 9352738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology and risk factors for chronic kidney disease in Chinese patients with biopsy-proven lupus nephritis.
    Sui M; Ye X; Ma J; Yu C; Zhao S; Liu X; Li L; Cao J; Jia X; Xie R
    Intern Med J; 2015 Nov; 45(11):1167-72. PubMed ID: 26109241
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma ADAMTS-13 activity in proliferative lupus nephritis: a large cohort study from China.
    Tan Y; Luan ZQ; Hao JB; Song D; Yu F; Zhao MH
    Lupus; 2018 Mar; 27(3):389-398. PubMed ID: 28786769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.